Alnylam Pharmaceuticals
ALNY
#437
Rank
HK$419.07 B
Marketcap
HK$3,172
Share price
1.88%
Change (1 day)
68.45%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company